https://www.alphaview.kr/news/31850-transdigm-second-quarter-earnings-report-and-conference-call-set-for-tuesday-may AlphaView ko 2026-04-27T13:00:00.000Z TransDigm Second Quarter Earnings Report and Conference Call Set for Tuesday, May 5, 2026 https://www.alphaview.kr/news/31848-powerfleet-launches-advanced-ai-video-saas-solution-with-telus-amplifying-north AlphaView ko 2026-04-27T13:00:00.000Z Powerfleet Launches Advanced AI Video SaaS Solution with TELUS, Amplifying North American Growth Drive https://www.alphaview.kr/news/31851-carscoms-new-first-of-its-kind-ai-video-solution-turns-every-vehicle-into-high-i AlphaView ko 2026-04-27T13:00:00.000Z Cars.com's New First-of-Its-Kind AI Video Solution Turns Every Vehicle Into High-Intent Sales Engine https://www.alphaview.kr/news/31847-agroz-inc-announces-grant-of-malaysia-digital-status-for-agroz-group-sdn-bhd AlphaView ko 2026-04-27T13:00:00.000Z Agroz Inc. Announces Grant of Malaysia Digital Status for Agroz Group Sdn. Bhd. https://www.alphaview.kr/news/31849-carver-bancorp-inc-announces-slate-of-highly-qualified-director-candidates-for-2 AlphaView ko 2026-04-27T13:00:00.000Z Carver Bancorp, Inc. Announces Slate of Highly Qualified Director Candidates for 2026 Annual Meeting https://www.alphaview.kr/news/31844-jazz-pharmaceuticals-announces-fda-acceptance-and-priority-review-of-supplementa AlphaView ko 2026-04-27T12:45:00.000Z Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA https://www.alphaview.kr/news/31828-biomarin-to-host-first-quarter-2026-financial-results-conference-call-and-webcas AlphaView ko 2026-04-27T12:30:00.000Z BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET https://www.alphaview.kr/news/31827-vision-marine-technologies-secures-conditional-tsx-venture-exchange-listing-appr AlphaView ko 2026-04-27T12:30:00.000Z Vision Marine Technologies Secures Conditional TSX Venture Exchange Listing Approval, Expanding Capital Markets Access for Its Marine Technology Platform https://www.alphaview.kr/news/31841-atlas-lithium-contracts-key-project-execution-partners-to-drive-its-neves-projec AlphaView ko 2026-04-27T12:30:00.000Z Atlas Lithium Contracts Key Project Execution Partners to Drive Its Neves Project Toward Production https://www.alphaview.kr/news/31842-seabridge-gold-provides-update-on-courageous-lake-spin-out-information-circular AlphaView ko 2026-04-27T12:30:00.000Z Seabridge Gold Provides Update on Courageous Lake Spin-Out Information Circular available on SEDAR+ Meeting Date: May 22nd, 2026 https://www.alphaview.kr/news/31822-one-capsule-endless-glow-radiant-skin-starts-within AlphaView ko 2026-04-27T12:07:00.000Z One Capsule, Endless Glow--Radiant Skin Starts Within https://www.alphaview.kr/news/31860-allarity-therapeutics-announces-that-the-stenoparib-drp-test-has-received-a-noti AlphaView ko 2026-04-27T12:00:00.000Z Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office https://www.alphaview.kr/news/31852-solsence-inc-announces-appointment-of-new-independent-director AlphaView ko 2026-04-27T12:00:00.000Z Solésence, Inc. Announces Appointment of New Independent Director https://www.alphaview.kr/news/31798-armata-pharmaceuticals-announces-appointment-of-biopharmaceutical-commercial-exe AlphaView ko 2026-04-27T12:00:00.000Z Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors https://www.alphaview.kr/news/31800-solstice-advanced-materials-declares-dividend-of-0075-per-common-share AlphaView ko 2026-04-27T12:00:00.000Z Solstice Advanced Materials Declares Dividend of $0.075 per Common Share https://www.alphaview.kr/news/31799-shoulder-innovations-initiates-full-commercial-launch-of-the-inset-i-135rfx-hume AlphaView ko 2026-04-27T12:00:00.000Z Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem https://www.alphaview.kr/news/31820-iamgold-publishes-2025-annual-sustainability-report AlphaView ko 2026-04-27T12:00:00.000Z IAMGOLD Publishes 2025 Annual Sustainability Report https://www.alphaview.kr/news/31821-nexmetals-reports-metallurgical-results-confirming-separate-high-grade-saleable AlphaView ko 2026-04-27T12:00:00.000Z NexMetals Reports Metallurgical Results Confirming Separate High Grade Saleable Cu-Ni-PGE Concentrates and Demonstrating Improved Recoveries at Selkirk https://www.alphaview.kr/news/31853-lifemd-to-report-first-quarter-2026-financial-results-on-may-6 AlphaView ko 2026-04-27T12:00:00.000Z LifeMD to Report First Quarter 2026 Financial Results on May 6 https://www.alphaview.kr/news/31861-shell-announces-agreement-to-acquire-canadian-energy-company-arc-resources-ltd-a AlphaView ko 2026-04-27T12:00:00.000Z Shell announces agreement to acquire Canadian energy company, ARC Resources Ltd (“ARC”). https://www.alphaview.kr/news/31854-aspida-life-and-market-synergy-group-launch-bitcoin-linked-index-across-synergy AlphaView ko 2026-04-27T12:00:00.000Z Aspida Life and Market Synergy Group Launch Bitcoin-Linked Index Across Synergy Choice™ Fixed Index Annuity Suite https://www.alphaview.kr/news/31856-biovie-to-host-virtual-kol-event-to-discuss-the-phase-2-study-of-bezisterim-for AlphaView ko 2026-04-27T12:00:00.000Z BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 https://www.alphaview.kr/news/31857-franklin-electric-declares-quarterly-dividend-of-028-per-share AlphaView ko 2026-04-27T12:00:00.000Z Franklin Electric Declares Quarterly Dividend of $0.28 Per Share https://www.alphaview.kr/news/31855-real-world-data-on-exparel-shows-reduced-opioid-use-and-lower-total-medical-cost AlphaView ko 2026-04-27T12:00:00.000Z Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty https://www.alphaview.kr/news/31858-kaltura-unveils-avatar-powered-roleplay-solution-for-enterprise-training-and-sim AlphaView ko 2026-04-27T12:00:00.000Z Kaltura Unveils Avatar-Powered Roleplay Solution for Enterprise Training and Simulations https://www.alphaview.kr/news/31859-evaxion-promotes-birgitte-rn-to-joint-role-of-chief-scientific-and-chief-operati AlphaView ko 2026-04-27T12:00:00.000Z Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer https://www.alphaview.kr/news/31846-firstcash-announces-commencement-of-offering-of-senior-notes AlphaView ko 2026-04-27T11:50:00.000Z FirstCash Announces Commencement of Offering of Senior Notes https://www.alphaview.kr/news/31794-lilly-to-acquire-ajax-therapeutics-to-advance-outcomes-for-patients-with-myelofi AlphaView ko 2026-04-27T11:45:00.000Z Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera https://www.alphaview.kr/news/31845-oceanfirst-financial-corp-and-flushing-financial-corporation-announce-receipt-of AlphaView ko 2026-04-27T11:45:00.000Z OceanFirst Financial Corp. and Flushing Financial Corporation Announce Receipt of All Requisite Regulatory and Shareholder Approvals to Complete Proposed Merger and Annual Meeting Date https://www.alphaview.kr/news/31843-clearmind-medicine-announces-evaluation-of-its-psychedelic-based-treatment-meai AlphaView ko 2026-04-27T11:41:00.000Z Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation https://www.alphaview.kr/news/31840-new-research-reveals-the-hidden-leadership-crisis-hiding-in-plain-sight-54-of-le AlphaView ko 2026-04-27T11:32:00.000Z New Research Reveals The Hidden Leadership Crisis Hiding In Plain Sight: 54% Of Leaders Are Producing Anxiety, Drift, And Disengagement – And Most Have No Idea https://www.alphaview.kr/news/31789-vertiv-strengthens-liquid-cooling-system-capability-with-acquisition-of-strategi AlphaView ko 2026-04-27T11:30:00.000Z Vertiv Strengthens Liquid-Cooling System Capability with Acquisition of Strategic Thermal Labs https://www.alphaview.kr/news/31790-cgi-launches-high-security-sovereign-ai-platform-in-finland-for-enterprise-and-p AlphaView ko 2026-04-27T11:30:00.000Z CGI launches high-security sovereign AI platform in Finland for enterprise and public sector use https://www.alphaview.kr/news/31791-ituran-location-and-control-ltd-schedules-first-quarter-2026-results-release-and AlphaView ko 2026-04-27T11:30:00.000Z ITURAN LOCATION AND CONTROL LTD. SCHEDULES FIRST QUARTER 2026 RESULTS RELEASE AND CONFERENCE CALL FOR MAY 26, 2026 https://www.alphaview.kr/news/31788-viavi-announces-investment-in-pcie-70-protocol-analysis-testing-platform AlphaView ko 2026-04-27T11:30:00.000Z VIAVI Announces Investment in PCIe 7.0 Protocol Analysis Testing Platform https://www.alphaview.kr/news/31787-gold-royalty-announces-record-first-quarter-2026-preliminary-results AlphaView ko 2026-04-27T11:30:00.000Z Gold Royalty Announces Record First Quarter 2026 Preliminary Results https://www.alphaview.kr/news/31786-hyperscale-data-subsidiary-ault-global-commodities-partners-with-scottsdale-mint AlphaView ko 2026-04-27T11:30:00.000Z Hyperscale Data Subsidiary Ault Global Commodities Partners with Scottsdale Mint to Advance Company's Precious Metals and Rare Earth Minerals Strategy https://www.alphaview.kr/news/31792-americas-gold-and-silver-corporation-provides-update-on-significant-capital-proj AlphaView ko 2026-04-27T11:30:00.000Z Americas Gold and Silver Corporation Provides Update on Significant Capital Projects Underway at Galena Complex as Part of Its Growth and Optimization Strategy in the Silver Valley https://www.alphaview.kr/news/31836-hcw-biologics-delivers-a-major-update-for-its-t-cell-engager-program-revealing-m AlphaView ko 2026-04-27T11:30:00.000Z HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors https://www.alphaview.kr/news/31829-cadv-ventures-sa-to-combine-with-miluna-acquisition-corp-to-become-a-publicly-li AlphaView ko 2026-04-27T11:30:00.000Z CADV Ventures S.A. to Combine with Miluna Acquisition Corp to Become a Publicly Listed Company https://www.alphaview.kr/news/31833-kustom-entertainment-to-highlight-strategic-progress-at-the-16th-annual-ld-micro AlphaView ko 2026-04-27T11:30:00.000Z KUSTOM ENTERTAINMENT TO HIGHLIGHT STRATEGIC PROGRESS AT THE 16th ANNUAL LD MICRO INVITATIONAL https://www.alphaview.kr/news/31832-greenlane-holdings-regains-compliance-with-nasdaq-minimum-bid-price-requirement AlphaView ko 2026-04-27T11:30:00.000Z Greenlane Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement https://www.alphaview.kr/news/31834-nervgen-pharma-strengthens-leadership-team-with-appointment-of-keith-vendola-as AlphaView ko 2026-04-27T11:30:00.000Z NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer https://www.alphaview.kr/news/31831-urban-gro-inc-nasdaq-ugro-issues-comprehensive-business-update-strategic-transfo AlphaView ko 2026-04-27T11:30:00.000Z urban-gro, Inc. (Nasdaq: UGRO) Issues Comprehensive Business Update: Strategic Transformation from Controlled Environment Agriculture to Sports, Media, and Experiential Platform; Restored Nasdaq Listing Compliance; Cricket Strategy Aligned with LA28 Olympic Inclusion and Growth of US Collegiate Cricket https://www.alphaview.kr/news/31830-cormedix-therapeutics-announces-positive-topline-results-from-phase-iii-respect AlphaView ko 2026-04-27T11:30:00.000Z CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients https://www.alphaview.kr/news/31837-tovecimig-demonstrates-statistically-significant-benefit-in-companion-002-random AlphaView ko 2026-04-27T11:30:00.000Z Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer https://www.alphaview.kr/news/31838-medicus-pharma-ceo-meets-with-lawmakers-on-energy-commerce-committee-on-capitol AlphaView ko 2026-04-27T11:30:00.000Z Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill https://www.alphaview.kr/news/31835-weight-watchers-announces-actions-to-utilize-up-to-40-million-to-pay-down-debt AlphaView ko 2026-04-27T11:30:00.000Z Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt https://www.alphaview.kr/news/31839-briacell-announces-six-clinical-data-presentations-at-asco-2026 AlphaView ko 2026-04-27T11:30:00.000Z BriaCell Announces Six Clinical Data Presentations at ASCO 2026 https://www.alphaview.kr/news/31826-scorpio-tankers-inc-announces-new-credit-facility AlphaView ko 2026-04-27T11:28:44.000Z Scorpio Tankers Inc. Announces New Credit Facility https://www.alphaview.kr/news/31825-alterity-therapeutics-receives-positive-fda-feedback-following-second-type-c-mee AlphaView ko 2026-04-27T11:25:00.000Z Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy https://www.alphaview.kr/news/31824-sagimet-biosciences-announces-pricing-of-1750-million-underwritten-offering-of-s AlphaView ko 2026-04-27T11:15:04.000Z Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock https://www.alphaview.kr/news/31823-allot-to-release-first-quarter-2026-results-and-host-conference-call-on-may-12-2 AlphaView ko 2026-04-27T11:07:06.000Z Allot to Release First Quarter 2026 Results and Host Conference Call on May 12, 2026 https://www.alphaview.kr/news/31782-dominos-pizza-announces-first-quarter-2026-financial-results AlphaView ko 2026-04-27T11:05:00.000Z Domino's Pizza® Announces First Quarter 2026 Financial Results https://www.alphaview.kr/news/31805-sionna-therapeutics-completes-enrollment-in-precision-cf-phase-2a-trial-evaluati AlphaView ko 2026-04-27T11:00:00.000Z Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis https://www.alphaview.kr/news/31806-fulcrum-therapeutics-announces-recent-business-highlights-and-financial-results AlphaView ko 2026-04-27T11:00:00.000Z Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 https://www.alphaview.kr/news/31812-sagimet-biosciences-provides-strategic-and-corporate-updates AlphaView ko 2026-04-27T11:00:00.000Z Sagimet Biosciences Provides Strategic and Corporate Updates https://www.alphaview.kr/news/31802-verizons-transformation-actions-deliver-growth-profitability-in-1q26-company-rai AlphaView ko 2026-04-27T11:00:00.000Z Verizon’s Transformation Actions Deliver Growth & Profitability in 1Q26; Company Raises Adjusted EPS Guidance https://www.alphaview.kr/news/31804-astec-announces-quarterly-dividend AlphaView ko 2026-04-27T11:00:00.000Z Astec Announces Quarterly Dividend https://www.alphaview.kr/news/31803-oruka-therapeutics-announces-positive-week-16-data-for-orka-001-from-the-ongoing AlphaView ko 2026-04-27T11:00:00.000Z Oruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-to-Severe Plaque Psoriasis https://www.alphaview.kr/news/31807-aeluma-appoints-willy-rachmady-vice-president-of-strategic-partnerships-and-ecos AlphaView ko 2026-04-27T11:00:00.000Z Aeluma Appoints Willy Rachmady Vice President of Strategic Partnerships and Ecosystem https://www.alphaview.kr/news/31801-martin-marietta-appoints-christopher-w-samborski-chief-operating-officer AlphaView ko 2026-04-27T11:00:00.000Z Martin Marietta Appoints Christopher W. Samborski Chief Operating Officer https://www.alphaview.kr/news/31809-ligand-to-acquire-xoma-royalty-further-accelerating-profit-growth-and-strengthen AlphaView ko 2026-04-27T11:00:00.000Z Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator https://www.alphaview.kr/news/31815-harrow-to-report-first-quarter-2026-financial-results-after-market-close-on-may AlphaView ko 2026-04-27T11:00:00.000Z Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026 https://www.alphaview.kr/news/31816-cardiff-oncology-to-host-key-opinion-leader-discussion-on-onvansertibs-promising AlphaView ko 2026-04-27T11:00:00.000Z Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity https://www.alphaview.kr/news/31818-gxo-accelerates-into-us-motorsports-as-official-partner-to-arrow-mclaren AlphaView ko 2026-04-27T11:00:00.000Z GXO Accelerates Into U.S. Motorsports as Official Partner to Arrow McLaren https://www.alphaview.kr/news/31810-moonfox-alternative-data-redefines-china-insights-at-neudata-hong-kong-summit-a AlphaView ko 2026-04-27T11:00:00.000Z MoonFox Alternative Data Redefines China Insights at Neudata Hong Kong Summit: A Triple-Threat of Online, Offline, and Transactional Data https://www.alphaview.kr/news/31813-ocular-therapeutix-to-participate-in-may-scientific-and-investor-conferences AlphaView ko 2026-04-27T11:00:00.000Z Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences https://www.alphaview.kr/news/31808-youxin-technology-announces-to-strategically-acquire-yatop-worth-108-million-sha AlphaView ko 2026-04-27T11:00:00.000Z Youxin Technology Announces to Strategically Acquire YATOP Worth $10.8 Million Shares to Expand Global TikTok Ecosystem and Digital Commerce Capabilities https://www.alphaview.kr/news/31811-seer-board-of-directors-unanimously-rejects-revised-unsolicited-proposal-from-ra AlphaView ko 2026-04-27T11:00:00.000Z Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group https://www.alphaview.kr/news/31814-intellia-therapeutics-initiates-rolling-submission-of-biologics-license-applicat AlphaView ko 2026-04-27T11:00:00.000Z Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema https://www.alphaview.kr/news/31819-altimmune-announces-closing-of-225-million-oversubscribed-public-offering-of-sec AlphaView ko 2026-04-27T11:00:00.000Z Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities https://www.alphaview.kr/news/31817-us-energy-corp-signs-five-year-helium-offtake-agreement-with-investment-grade-gl AlphaView ko 2026-04-27T11:00:00.000Z U.S. Energy Corp. Signs Five-Year Helium Offtake Agreement with Investment-Grade Global Leader in Industrial Gases https://www.alphaview.kr/news/31797-schmid-group-nv-provides-q1-2026-business-update-and-balance-sheet-strengthening AlphaView ko 2026-04-27T10:56:08.000Z SCHMID Group N.V. Provides Q1 2026 Business Update and Balance-sheet Strengthening https://www.alphaview.kr/news/31796-fulcrum-therapeutics-appoints-josh-lehrer-to-its-board-of-directors AlphaView ko 2026-04-27T10:55:00.000Z Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors https://www.alphaview.kr/news/31795-eton-pharmaceuticals-announces-initiation-of-clinical-study-for-product-candidat AlphaView ko 2026-04-27T10:50:00.000Z Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 https://www.alphaview.kr/news/31784-parsons-marks-groundbreaking-of-sr-400-express-lanes-project-in-georgia AlphaView ko 2026-04-27T10:30:00.000Z Parsons Marks Groundbreaking of SR 400 Express Lanes Project in Georgia https://www.alphaview.kr/news/31785-super-hi-announces-annual-general-meeting-on-june-12-2026-and-filing-of-its-annu AlphaView ko 2026-04-27T10:30:00.000Z Super Hi Announces Annual General Meeting on June 12, 2026 and Filing of Its Annual Report on Form 20-F https://www.alphaview.kr/news/31783-amaze-signs-loi-with-digital-innovations-holding-group-inc-to-integrate-irma-eng AlphaView ko 2026-04-27T10:30:00.000Z Amaze Signs LOI with Digital Innovations Holding Group, Inc. to Integrate IRMA Engine to Expand Creator and Fan Monetization Through Paid Influencer Program https://www.alphaview.kr/news/31776-ifs-appoints-ryan-courson-as-chief-financial-officer AlphaView ko 2026-04-27T10:07:00.000Z IFS Appoints Ryan Courson as Chief Financial Officer https://www.alphaview.kr/news/31781-owlting-group-nasdaq-owls-to-announce-full-year-2025-financial-results AlphaView ko 2026-04-27T10:03:00.000Z OwlTing Group (NASDAQ: OWLS) to Announce Full Year 2025 Financial Results https://www.alphaview.kr/news/31779-allied-gaming-entertainment-announces-temporary-no-sale-non-binding-commitment-b AlphaView ko 2026-04-27T10:00:00.000Z Allied Gaming & Entertainment Announces Temporary No-Sale non-binding Commitment by Major Shareholder https://www.alphaview.kr/news/31778-relay-therapeutics-announces-clinical-data-for-zovegalisib-plus-atirmociclib-tri AlphaView ko 2026-04-27T10:00:00.000Z Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer https://www.alphaview.kr/news/31780-kbrs-mission-technology-solutions-awarded-200-million-to-accelerate-safer-smarte AlphaView ko 2026-04-27T10:00:00.000Z KBR’s Mission Technology Solutions Awarded $200 Million to Accelerate Safer, Smarter US Transportation Systems https://www.alphaview.kr/news/31777-euda-health-holdings-limited-has-received-notice-from-nasdaq-that-it-has-failed AlphaView ko 2026-04-27T10:00:00.000Z EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities https://www.alphaview.kr/news/31775-onsemi-and-nio-expand-strategic-collaboration-to-accelerate-next-generation-900v AlphaView ko 2026-04-27T09:00:00.000Z onsemi and NIO Expand Strategic Collaboration to Accelerate Next-Generation 900V EV Platforms https://www.alphaview.kr/news/31774-ataibeckley-and-psypan-receive-a-silver-award-in-2026-patient-participant-index AlphaView ko 2026-04-27T08:05:00.000Z AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research https://www.alphaview.kr/news/31773-fti-consulting-appoints-mike-davies-to-capital-markets-practice AlphaView ko 2026-04-27T08:00:00.000Z FTI Consulting Appoints Mike Davies to Capital Markets Practice https://www.alphaview.kr/news/31771-broadridge-transforming-financial-literacy-in-ireland-through-ai-powered-communi AlphaView ko 2026-04-27T07:00:00.000Z Broadridge Transforming Financial Literacy in Ireland Through AI-Powered Communication https://www.alphaview.kr/news/31770-nbpe-announces-audited-annual-financial-report-and-31-march-2026-monthly-nav AlphaView ko 2026-04-27T06:00:00.000Z NBPE Announces Audited Annual Financial Report and 31 March 2026 monthly NAV https://www.alphaview.kr/news/31772-garrett-motions-breakthrough-oil-free-centrifugal-compressor-enhances-high-effic AlphaView ko 2026-04-27T06:00:00.000Z Garrett Motion’s Breakthrough Oil-Free Centrifugal Compressor Enhances High-Efficiency Liquid Cooling Solutions https://www.alphaview.kr/news/31769-weride-and-lenovo-collaborate-to-deploy-200000-autonomous-vehicles-globally-over AlphaView ko 2026-04-27T05:53:12.000Z WeRide and Lenovo Collaborate to Deploy 200,000 Autonomous Vehicles Globally Over Five Years https://www.alphaview.kr/news/31768-apollo-funds-to-acquire-forvias-automotive-interiors-business AlphaView ko 2026-04-27T05:30:00.000Z Apollo Funds to Acquire Forvia’s Automotive Interiors Business https://www.alphaview.kr/news/31767-protiviti-congratulates-brand-ambassador-matt-fitzpatrick-as-fitzpatrick-brother AlphaView ko 2026-04-27T02:33:00.000Z Protiviti Congratulates Brand Ambassador Matt Fitzpatrick as Fitzpatrick Brothers Win Zurich Classic of New Orleans https://www.alphaview.kr/news/31766-the-trade-desk-powers-open-internet-growth-with-dramabox-short-drama-partnership AlphaView ko 2026-04-27T02:00:00.000Z The Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership https://www.alphaview.kr/news/31765-data-at-heart-rhythm-2026-highlight-key-boston-scientific-therapies AlphaView ko 2026-04-26T18:00:00.000Z Data at Heart Rhythm 2026 highlight key Boston Scientific therapies https://www.alphaview.kr/news/31764-oruka-therapeutics-to-host-conference-call-to-report-week-16-data-for-orka-001-f AlphaView ko 2026-04-26T16:00:00.000Z Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026 https://www.alphaview.kr/news/31763-abbott-showcases-strength-of-its-technologies-to-address-abnormal-heart-rhythms AlphaView ko 2026-04-25T17:30:00.000Z Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 https://www.alphaview.kr/news/31762-medtronic-announces-key-affera-clinical-study-milestones-for-sphere-9-and-sphere AlphaView ko 2026-04-25T17:30:00.000Z Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues https://www.alphaview.kr/news/31761-american-express-bank-of-america-mastercard-in-losers-weeks-financials-wrap-xlfn AlphaView ko 2026-04-25T14:00:11.000Z American Express, Bank of America, Mastercard in losers: week's financials wrap (XLF:NYSEARCA) https://www.alphaview.kr/news/31758-truist-financial-sticks-to-its-buy-rating-for-mastercard-ma AlphaView ko 2026-04-25T13:43:05.000Z Truist Financial Sticks to Its Buy Rating for Mastercard (MA)